BP
DVAX

Ballentine Partners’s Dynavax Technologies DVAX Stock Holding History

Ballentine Partners’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,741
Closed -$137K – 935
2024
Q4 		$137K Buy
+10,741
New +$130K ﹤0.01% 815

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ballentine Partners's DVAX Position: Q1 2025 in Review

Ballentine Partners sold out of Dynavax Technologies (DVAX) in Q1 2025, closing a stake of 10,741 shares — an estimated $137K sold.

Ballentine Partners first reported a position in DVAX in Q4 2024 and held it in 1 quarter. The position peaked at $137K in Q4 2024. 284 funds tracked by Wall St. Rank hold DVAX as of Q1 2025.

  • Ballentine Partners reported no remaining Dynavax Technologies position as of Q1 2025 after selling out during the quarter.
  • Ballentine Partners sold 10,741 Dynavax Technologies shares in Q1 2025, an estimated $137K.
  • Ballentine Partners first reported a position in Dynavax Technologies in Q4 2024 and held it in 1 quarter.
  • Ballentine Partners's Dynavax Technologies position peaked at $137K in Q4 2024.
  • 284 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2025.

Based on Ballentine Partners's 13F filing for Q1 2025, filed 1 May 2025.